Home » Topics » Disease categories and therapies » Immune

Immune
RSS

NIH offers malaria vaccine technology for licensing

April 3, 1998

Zenapax launched in Switzerland

March 17, 1998

Immunosuppressive analogues of a natural immunostimulant

March 16, 1998

New malaria vaccine described in patent literature

March 16, 1998

Novel immunomodulatory agents described by Takeda

March 12, 1998

Alliance formed for development of oral vaccines from plants

March 11, 1998

PGG-glucan displays potent protective effects in guinea pig model

March 10, 1998

PowderJect and Glaxo Wellcome enter DNA vaccine collaboration

March 10, 1998

Boston Life Sciences licenses BCLx-gamma gene from Harvard

March 10, 1998

Zenapax approved in Switzerland

March 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...